Press Release

TESS Research Foundation today announced a new research grant award to Neurolentech in the search for a cure for the rare disease SLC13A5 Epilepsy. The Austrian startup Neurolentech, led by Carsten Pfeffer, PhD and co-founded by Gaia Novarino, PhD, Professor of Neuroscience at Institute of Science and Technology Austria (IST Austria), will receive $224,064 toward research projects that will model SLC13A5 Epilepsy in patient-derived SLC13A5 cells.